GKOS Stock Analysis: Buy, Sell, or Hold?
GKOS - Glaukos Corporation
$142.15
4.86 (3.54%)
▲
5d:
+5.96%
30d:
+17.48%
90d:
+33.17%
BUY
MODERATE Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 06, 2026
0d
Smart Money Accumulation
GKOS is down 4.8% this week, but smart money is accumulating calls. Top strike: $135 2026-06-18 with 7 OI. Call ratio: 88% View Scanner →
Strength: 6.2/10
Get Alerted When GKOS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: GKOS shows positive signals but monitor for confirmation. Market pricing in 3.1% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: GKOS shows positive signals but monitor for confirmation. Market pricing in 3.1% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$16.75
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$10.40
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: GKOS is currently trading at $142.15, which is considered extended relative to its 30-day fair value range of $117.88 to $135.24. The stock's valuation (Forward PE: 297.2) is in line with its historical norms (271.1). At these levels, the market is pricing in 3.1% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, GKOS is in a uptrend. Immediate support is located at $130.04, while resistance sits at $146.75. The stock is showing strong short-term momentum, up 3.5% recently.
Market Sentiment: GKOS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (23th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, GKOS is in a uptrend. Immediate support is located at $130.04, while resistance sits at $146.75. The stock is showing strong short-term momentum, up 3.5% recently.
Market Sentiment: GKOS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (23th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$117.88 -
$135.24
Company Quality Score
62/100
(BUY)
Options IV Signal
23th percentile
(COMPLACENCY WARNING)
Volume Confirmation
HIGH
Confidence Score
66.2%
All Signals
- BEARISH: Price extended above range (+5.1% above its trading range)
- BULLISH: Options cheap (IV 23th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.5%)
- NEUTRAL: Near Wall St target ($151.08)
- NEUTRAL: Market pricing in 3.1% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$117.88 -
$135.24
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$10.28
(7.2%)
Support & Resistance Levels
Support Level
$130.04
Resistance Level
$146.75
Current Trend
Uptrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
297.20
Wall Street Target
$151.08
(+6.3%)
Revenue Growth (YoY)
41.2%
Earnings Growth (YoY)
1896.3%
Profit Margin
-34.3%
Valuation Premium vs History
+3.1% premium
PE vs Historical
297.2 vs 271.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.1%
(market-implied from PE analysis)
1-Year Target
$146.56
(+3%)
2-Year Target
$151.10
(+6%)
3-Year Target
$155.78
(+10%)
3-Yr Target (if PE normalizes)
(PE: 297→271)
PE COMPRESSION
$142.10
(0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: May 14, 2026 10:07 PM ET
Data refreshes hourly during market hours. Next update: 11:07 PM
Data refreshes hourly during market hours. Next update: 11:07 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GKOS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
12
Sells
Net
INSIDERS SELLING
Recent Transactions
Alex R Thurman
SELL
2511 shares
2026-03-25
Alex R Thurman
SELL
1521 shares
2026-03-24
Alex R Thurman
SELL
625 shares
2026-03-17
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$85 | 55 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$392 | 62 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$84 | 60 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 53 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$250 | 58 HOLD |
Advanced GKOS Option Strategies
Professional options setups generated by AI based on today's GKOS price and gamma walls.
